Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Burning Rock Biotech Ltd

BNR · Nasdaq · CIK 0001792267 · Healthcare · Diagnostics & Research

INSIDER SIGNAL

60.6 / 100

1 buyers · 7 purchase transaction lines · $6.2M gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeStrong
RoleStrong
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+22.1 / 25
Role+20.0 / 20
Recency+1.5 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Han YushengDirector
●●●●●●●
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: Han Yusheng · $6.2M
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-06-11–2026-06-26

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

60.6 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 60.8
  2. 60.8
  3. 60.7
  4. 60.7
  5. 60.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

7Purchases
0Sales
0Other Form 4 lines
1SEC filings · 365 days
BUYING7 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+33.3%
3M
+45.3%
6M
-2.2%
12M
+74.0%

Volatility & liquidity

Volatility
122.1%
Beta
—
Avg daily value
USD 439,695

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-10.3%
ROE
-10.3%
Industry
Diagnostics & Research

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
41,425
Previous report
39,415
Avg daily volume
41,873
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-26Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)24,900USD 8.00USD 199,200SEC filing ↗
2026-06-24Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)250,000USD 8.00USD 2,000,000SEC filing ↗
2026-06-23Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)5,990USD 7.50USD 44,925SEC filing ↗
2026-06-22Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)104,650USD 7.45USD 779,642SEC filing ↗
2026-06-16Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)111,110USD 9.00USD 999,990SEC filing ↗
2026-06-12Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)210,000USD 9.25USD 1,942,500SEC filing ↗
2026-06-11Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)24,760USD 8.74USD 216,402SEC filing ↗

Form 4 evidence

7 transaction lines in the latest 365-day window; 7 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-26Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)24,900USD 8.00USD 199,200SEC filing ↗
2026-06-24Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)250,000USD 8.00USD 2,000,000SEC filing ↗
2026-06-23Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)5,990USD 7.50USD 44,925SEC filing ↗
Show recent Form 4 evidence (7 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-26Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)24,900USD 8.00USD 199,200SEC filing ↗
2026-06-24Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)250,000USD 8.00USD 2,000,000SEC filing ↗
2026-06-23Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)5,990USD 7.50USD 44,925SEC filing ↗
2026-06-22Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)104,650USD 7.45USD 779,642SEC filing ↗
2026-06-16Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)111,110USD 9.00USD 999,990SEC filing ↗
2026-06-12Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)210,000USD 9.25USD 1,942,500SEC filing ↗
2026-06-11Han YushengPurchase (P)Ordinary Shares (represented by American depositary shares)24,760USD 8.74USD 216,402SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerBNR
CIK0001792267
SectorHealthcare
IndustryDiagnostics & Research Yahoo Finance
SEC SIC8071 Services-Medical Laboratories
ExchangeNasdaq

Data coverage

Local Form 4 history7 transaction lines from 2026-06-11 to 2026-06-26
7 P purchase lines · 0 S sale lines · 0 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.